With IV administration, the vitamins bypass the digestive system, allowing for higher absorption rates and delivering the vitamins directly into the bloodstream for immediate use by the body
The study received funding from Wellcome, Medical Research Council, European Union Horizon 2020 Programme, the National Institutes of Health (grants U01-DK105535, U01-DK085545 and UM-1DK126185), the National Institute for Health Research Oxford Biomedical Research Centre, the Canadian Institutes of Health Research, the Novo Nordisk Foundation, Boehringer Ingelheim and Diabetes Australia.
Clinical trials showed an average of ~6% weight reduction after 12 weeks, then ~10% after 20 weeks
This can help prevent future occurrences and may be important for legal or medical follow-ups
This formula is designed to help support energy levels in both the body and mind, enabling enhanced participation in daily activities
BioLongevity Labs supplies 5-Amino-1MQ for research use only
